Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goethals, I.
Right arrow Articles by Van De Wiele, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goethals, I.
Right arrow Articles by Van De Wiele, C.
Related Collections
Right arrow 2002 - Review Articles
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:1331-1339, 2002
© 2002 European Society for Medical Oncology

Review Article

The clinical value of nuclear medicine in the assessment of irradiation-induced and anthracycline-associated cardiac damage

I. Goethals1,+, O. De Winter1, P. De Bondt1, J. De Sutter2, R. Dierckx1 and C. Van De Wiele1

1 Division of Nuclear Medicine, 2 Department of Cardiology, Ghent University Hospital, Ghent, Belgium

Received 2 May 2002; accepted 18 June 2002

Abstract

Two groups of patients, those treated for Hodgkin’s disease and breast cancer, are particularly at risk of developing late myocardial damage, since radiotherapy (RT) techniques for both patient groups may include (large) parts of the heart, and adjuvant systemic therapy is frequently administered to these patients, in particular anthracycline-containing chemotherapy. Available literature on the monitoring and prediction of RT-induced and anthracycline-associated cardiac damage using nuclear medicine techniques is presented. Based on relevant studies, the risk of overall cardiac disease post-RT and overt congestive heart failure during anthracycline-containing chemotherapy is probably low. Conventional nuclear medicine imaging, i.e. myocardial perfusion scintigraphy, may be of complementary use to echocardiographical evaluation for routine follow-up after RT with modern techniques, in a subgroup of patients with known cardiovascular risk factors. Left ventricle ejection fraction (LVEF) measurements, as assessed by radionuclide angiography for the monitoring of anthracycline-associated cardiac injury, are not very sensitive and early detection will probably be enhanced by combining LVEF measurements with other cardiac function parameters. Also, it may be expected that nuclear medicine techniques using molecular radioligands will constitute an essential future step in the evaluation of subclinical cardiac injury afforded by the combined effect of RT and cardiotoxic chemotherapy.

Key words: anthracycline-associated; cardiac damage; monitoring; nuclear medicine; prediction; radiotherapy-induced


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
P. J. Barrett-Lee, J. M. Dixon, C. Farrell, A. Jones, R. Leonard, N. Murray, C. Palmieri, C. J. Plummer, A. Stanley, and M. W. Verrill
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
Ann. Onc., May 1, 2009; 20(5): 816 - 827.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
I. W. Gayed, H. H. Liu, S. W. Yusuf, R. Komaki, X. Wei, X. Wang, J. Y. Chang, J. Swafford, L. Broemeling, and Z. Liao
The Prevalence of Myocardial Ischemia After Concurrent Chemoradiation Therapy as Detected by Gated Myocardial Perfusion Imaging in Patients with Esophageal Cancer
J. Nucl. Med., November 1, 2006; 47(11): 1756 - 1762.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.